Way Towards New Life

Skin Anti-Cancer Drugs

Alleviare promptly facilitates Indian patients and physicians under Named Patient Programs (NPP) to access imported authorized medicines that are not locally available to them.

Obtain access to an Skin Anti-Cancer Medicines (an unapproved drug in India) for personal use.

Here is a list of some of the Skin Anti-Cancer Drugs for which we currently have a NPP in place. If you are a patient or  healthcare professional, please click below on each to access details and information.

BRAFTOVI (encorafenib) capsules

It’s used to treat skin cancer called melanoma

MEKINIST (trametinib) for oral solution

It is approved to treat adults whose cancer cells have a specific genetic mutation (change) in their genes called ‘BRAF V600’.

MEKTOVI (binimetinib) tablets

It is approved to treat people with a type of skin cancer called melanoma.

ZELBORAF (vemurafenib) tablet

It is approved to treat melanoma

ZYNYZ (retifanlimab-dlwr) injection

It is approved to treat a type of skin cancer called Merkel cell carcinoma in adults.

For Indian Patient Enquiry under NPP.

For any urgent inquiries or assistance needed, please reach out to our Support Team. Rest assured, we will respond within 24 hours, from Monday to Saturday, during the hours of 9:00 A.M to 18:00 PM.

Access Under Named Patient Programs

Specialty Drugs

Here is a list of some of the products for which we currently have a NPP in place. If you are a patient or  healthcare professional, please click below on each to access details and information.

Lanadelumab For Injection

Approved the use of lanadelumab in August 2018, for people that are 12 years and older and have either type I or type II hereditary angioedema.

Valbenazine Capsules

It is a medication used to treat tardive dyskinesia. It acts as a vesicular monoamine transporter 2 (VMAT2) inhibitor.

Letermovir Injection

indicated for prophylaxis of cytomegalovirus (CMV) infection and disease in adult CMV-seropositive recipients [R+] of an allogeneic hematopoietic stem cell transplant (HSCT).

Olaratumab Injection

used to treat adults with advanced soft tissue sarcoma, a type of cancer that affects the soft, supportive tissues of the body such as muscles, blood vessels and fat tissue.

Query Form

We would love to speak with you.
Feel free to reach out using the below details.

Access Unauthorized Medicines In India Under NPP.

What is Named-patient access programme (NPP)?

Named-patient basis access can also refer to a medicine for a specific patient or patients that is not (yet) authorised and available to them in their own country. Such medicine should or must (depending on legislation) be authorised in at least one country, from which it can be imported into the patient’s country under a Named-patient access programme (NPP).

These may be medicines that are:

  • Authorised but not yet available to be prescribed in the patient’s country.
  • Authorised and available in one country but not authorised and available in the patient’s country.
  • Discontinued in the patient’s country but not in another country.
  • In shortage in the patient’s country but not in another country.

Antibiotic

Arthritis

Diabetes

Genetics

Disorders

Hepatitis C

Hematologic Cancers

HIV/AIDS

Immunological Disorders

Liver Disease

Multiple Sclerosis

Nerver Disease

Oncology

Parkinson's Disease

Rare Disease

Soft Tissue Sarcoma

Transplant

Specialty Drugs

Get Access to an Unapproved Drug

Get access to an unapproved drug for personal use to following cities in India – Ahmedabad, Aizawal, Aurangabad, Barshi, Bengaluru, Bhopal, Cachar, Chennai, Dibrugarh, Hyderabad, Karungapally, Kohima, Kollam, Kolkata, Mumbai, Meghalaya, Mizoram, Sikkim, Nagpur, New Delhi, Pondichery, Pune, Punjab, Thirunananthapuram, Tripura, Wardha

Disclaimer

All Trademarks and Brands that appear on the website belong to their respective owners. Alleviare provides only information & in any way, does not lay any claim on these brand names &/or trademarks.